Group One Trading
HUMA icon

Group One Trading’s Humacyte HUMA Stock Holding History

Group One Trading’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$38.3K Sell
63,200
-25,000
-28% -$26K ﹤0.01% 5466
2025
Q4 		$84.7K Buy
88,200
+18,900
+27% +$26.8K ﹤0.01% 5134
2025
Q3 		$121K Buy
69,300
+29,000
+72% +$56.8K ﹤0.01% 5162
2025
Q2 		$84.2K Sell
40,300
-4,100
-9% -$7.88K ﹤0.01% 5124
2025
Q1 		$75.7K Sell
44,400
-234,500
-84% -$880K ﹤0.01% 4830
2024
Q4 		$1.41M Buy
278,900
+143,400
+106% +$710K ﹤0.01% 2234
2024
Q3 		$737K Buy
135,500
+56,300
+71% +$371K ﹤0.01% 2560
2024
Q2 		$380K Sell
79,200
-6,700
-8% -$34.9K ﹤0.01% 2823
2024
Q1 		$267K Buy
85,900
+37,100
+76% +$125K ﹤0.01% 3309
2023
Q4 		$139K Buy
48,800
+30,000
+160% +$77K ﹤0.01% 4192
2023
Q3 		$55.1K Buy
18,800
+1,500
+9% +$4.96K ﹤0.01% 5006
2023
Q2 		$49.5K Buy
17,300
+11,500
+198% +$41.5K ﹤0.01% 5287
2023
Q1 		$17.9K Buy
+5,800
New +$16.5K ﹤0.01% 5582
2022
Q4 		– Sell
-129,500
Closed -$422K – 7607
2022
Q3 		$422K Sell
129,500
-10,300
-7% -$39.5K ﹤0.01% 3397
2022
Q2 		$449K Buy
139,800
+118,700
+563% +$660K ﹤0.01% 3531
2022
Q1 		$149K Buy
21,100
+17,000
+415% +$99K ﹤0.01% 5102
2021
Q4 		$30K Sell
4,100
-41,900
-91% -$414K ﹤0.01% 6723
2021
Q3 		$534K Buy
+46,000
New +$526K ﹤0.01% 4126

Other funds holding HUMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AP
Antipodes Partners Royal Exchange, Australia $5.19B AUM 36.17% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Group One Trading's HUMA Position: Q1 2026 in Review

Group One Trading reduced its Humacyte (HUMA) stake by 19% in Q1 2026, selling an estimated $51.1K and leaving 215,476 shares worth $131K. The position accounts for ﹤0.01% of the portfolio, ranked #4481.

Group One Trading first reported a position in HUMA in Q3 2021 and has held it in 14 quarters since. The position peaked at $301K in Q3 2024. 158 funds tracked by Wall St. Rank hold HUMA as of Q1 2026.

  • Group One Trading held 215,476 shares of Humacyte worth $131K as of Q1 2026.
  • Group One Trading sold 49,121 Humacyte shares in Q1 2026, an estimated $51.1K.
  • Humacyte made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #4481 holding.
  • Group One Trading first reported a position in Humacyte in Q3 2021 and has held it in 14 quarters since.
  • Group One Trading's Humacyte position peaked at $301K in Q3 2024.
  • 158 funds tracked by Wall St. Rank held Humacyte as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.